[ad_1]
The president of the United States Donald trump you were treated with a medicine made from fetal stem cells, taken after elective abortionsthat is, the terminations of pregnancy desired by mothers without any medical motivation, a practice that Trump has repeatedly denounced.
The therapy administered to Trump, who tested positive for coronavirus in recent weeks, would be a cocktail of monoclonal antibodies developed by Regeneron, and appears to be a promising cure, although at the moment has not yet received approval by the FDA, the agency that regulates drugs in the United States.
Trump treated with drug produced from fetus tissues
The President of the United States received a particular drug made from resistance cells called HEK-293T, first obtained from a fetus kidney, taken after an elective abortion. What is most debated is the fact that over the course of his political career the magnate has repeatedly tried to limit this practice. Also last month he appointed conservative Catholic Justice Amy Coney Barrett to the Supreme Court, and he’s right. anti-abortion movement which is based on one of its main supporting columns.
In fact, the Republican Party has repeatedly declared itself opposed to embryonic stem cell research and has called for a ban on federal funding for stem cell research. Last January, President Trump also stated: “We stopped federal funding for fetal tissue research, which everyone thought was very important. We are there oppose the pro-abortion lobby like never before “.
The same cells used for the drug administered to Trump are currently also being tested in several promising vaccines, the United States Conference of Catholic Bishops also spoke on the subject, writing a letter to the United States government, as reported Science magazine with which he states:
“It is vitally important that Americans have access to ethically produced vaccineNo American should be forced to choose between getting vaccinated against this potentially deadly virus and violating conscience.
The drug is still being tested
The drug that was given to Donald Trump is not yet available on the market and has so far been tested on only 275 people. The pharmaceutical company that produced this drug has been collaborating for years with the United States government to develop its own monoclonal antibody therapies. In 2018, the same cells were also used to produce a Ebola virus therapy, according to a study published in the Journal of Infectious Diseases. Regeneron in a statement last April had stated that:
“Research using these stem cells enables Regeneron to model complex diseases, test new drug candidates, and may help unlock new scientific insights that could ultimately lead to the discovery of new treatments for people with serious illnesses.”
